Dapagliflozin Propanediol
Brand name: Farxiga
Rank #10 of 500 drugs by total cost
$1.65B
Total Cost
1,666,200
Total Claims
$1.65B
Total Cost
39,474
Prescribers
$989
Cost per Claim
287,361
Beneficiaries
2,873,220
30-Day Fills
$42K
Avg Cost/Provider
42
Avg Claims/Provider
About Dapagliflozin Propanediol
Dapagliflozin Propanediol (sold as Farxiga) was prescribed 1,666,200 times by 39,474 Medicare Part D providers in 2023, costing the program $1.65B. At $989 per claim, this is a high-cost medication.
💰 This drug alone accounts for 0.6% of all Medicare Part D drug spending.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 7 | Lenalidomide (Revlimid) | $2.15B | 130,834 |
| 8 | Insulin Glargine,hum.Rec.Anlog (Lantus Solostar) | $1.94B | 3,118,259 |
| 9 | Fluticasone/Umeclidin/Vilanter (Trelegy Ellipta) | $1.81B | 2,046,216 |
| 10 | Dapagliflozin Propanediol (Farxiga) | $1.65B | 1,666,200 |
| 11 | Sitagliptin Phosphate (Januvia) | $1.54B | 1,567,668 |
| 12 | Sacubitril/Valsartan (Entresto) | $1.30B | 1,220,812 |
| 13 | Bictegrav/Emtricit/Tenofov Ala (Biktarvy) | $1.29B | 310,738 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology